Unlock valuable insights and stay updated on HFO-1234ze(E)

Honeywell’s Solstice® Air (HFO-1234ze(E), cGMP) uses Hydrofluoroolefin (HFO) technology, a sustainable alternative to HFAs in MDIs. With an ultra-low GWP, Solstice® Air is a breakthrough medical propellant currently in clinical development for MDIs with the ability to reduce greenhouse gas emissions of propellant by up to 99.9% vs current inhaler propellant. Solstice® Air does not contribute to ground-level ozone creation and is VOC-exempt per the U.S. Environmental Protection Agency (EPA) and the California Air Resource Board (CARB). 

Complete the form to access our comprehensive research list, and we'll deliver the report straight to your inbox.